IBM just introduced its new supercomputer, BlueGene, this week. It's hard not to be astonished by the new device, which can handle 1,000 billion calculations a second, the equivalent of 100,000 PCs in computing power, or, for those who like graphic descriptions, of a stack of P.C.'s 1.5 miles high.
Today, at the DIA conference, Microsoft announced the 2007 Pharma and Life Sciences Innovation award winners: Sales and marketing: H. Lundbeck AB, Helsingborg, Sweden, for innovation in CRM. Manufacturing and supply chain: PharmaZell GmbH, Rosenheimer, Germany, for use of ERP.
An article in Computer Weekly today addressed that question. It quotes Steven Dietz, head of IT for Quintiles, who worries that features in Microsoft's new operating system could "conflict with his third-party and home-grown defenses, leading to unintended data leakage." He's putting the OS through some rigorous testing and holding...
And many of them aren't from disgruntled employees, but from good people who may experience a lapse in judgement ("Hey mom, can I use your laptop for something? My computer's too slow") Today, Pharmalot reported that the personal data of 17,000 Pfizer employees (including social security numbers) was exposed, since...
We surveyed our readers last year to learn what they were doing in process control. We included a question on "open control" only to learn that most readers had not even heard of S-88 and S-95, key elements in more progressive automation platforms at companies that include Novartis, Genentech and Pfizer.
For anyone involved in any type of manufacturing, Toyota is the "gold standard" for efficiency. After all, how many companies can honestly claim that 80% of their manufacturing time is spent on activities that actually add value to their product? (Many drug companies would consider themselves lucky to reach 10%).
If drug development specialists spend up to 40% of their valuable time on administrative functions and looking for data, the same appears to hold for drug sales reps, too. More insights from Best Practices, LLC.
FDA and the California-based IT company, Conformia, have been at work for the past few years on a cooperative research and development agreement (CRADA) designed to analyze knowledge management within the drug industry and FDA, to pinpoint what is making drug development so costly.
Pharmaceutical Executive's Beth Herskovits has just reported that tens of thousands of pharma sales reps across the country are suing their current and former employees for overtime and the equivalent of "time and a half. " $1 billion in settlements could be at stake.